Document Detail


Nitric oxide in the regulation of vasomotor tone in human skeletal muscle.
MedLine Citation:
PMID:  10362675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of nitric oxide (NO) as a regulator of vasomotor tone has been investigated in resting and exercising human skeletal muscle. At rest, NO synthase (NOS) inhibition by intra-arterial infusion of NG-monomethyl-L-arginine decreased femoral artery blood flow (FABF, ultrasound Doppler) from 0.39 +/- 0.08 to 0.18 +/- 0.03 l/min (P < 0. 01), i.e., by approximately 52%, and increased leg O2 extraction from 62.1 +/- 9.8 to 100.9 +/- 4.5 ml/l (P < 0.004); thus leg O2 uptake (VO2, 22 +/- 4 ml/min, approximately 0.75 ml. min-1. 100 g-1) was unaltered [not significant (P = NS)]. Mean arterial pressure (MAP) increased by 8 +/- 2 mmHg (P < 0.01). Heart rate (HR, 53 +/- 3 beats/min) was unaltered (P = NS). The NOS inhibition had, however, no effect on the initial rate of rise or the magnitude of FABF (4.8 +/- 0.4 l/min, approximately 163 ml. min-1. 100 g-1), MAP (117 +/- 3 mmHg), HR (98 +/- 5 beats/min), or leg VO2 (704 +/- 55 ml/min, approximately 24 ml. min-1. 100 g-1, P = NS) during submaximal, one-legged, dynamic knee-extensor exercise. Similarly, FABF (7.6 +/- 1.0 l/min, approximately 258 ml. min-1. 100 g-1), MAP (140 +/- 8 mmHg), and leg VO2 (1,173 +/- 139 ml/min, approximately 40 ml. min-1. 100 g-1) were unaffected at termination of peak effort (P = NS). Peak HR (137 +/- 3 beats/min) was, however, lowered by 10% (P < 0.01). During recovery, NOS inhibition reduced FABF by approximately 34% (P < 0.04), which was compensated for by an increase in the leg O2 extraction by approximately 41% (P < 0.04); thus leg VO2 was unaltered (P = NS). In conclusion, these findings indicate that NO is not essential for the initiation or maintenance of active hyperemia in human skeletal muscle but support a role for NO during rest, including recovery from exercise. Moreover, changes in blood flow during rest and recovery caused by NOS inhibition are accompanied by reciprocal changes in O2 extraction, and thus VO2 is maintained.
Authors:
G Rådegran; B Saltin
Related Documents :
840905 - Comparison of oxygen uptake and heart rate during exercises on land and in water.
1886485 - Physiological responses to wrist weights during endurance cycling in normal subjects.
3781995 - Effect of posture on vital capacity.
15181165 - Human forearm position sense after fatigue of elbow flexor muscles.
464175 - Recommendations for the screening of military personnel over 35 years of age for physic...
20479615 - Role of beta-alanine supplementation on muscle carnosine and exercise performance.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of physiology     Volume:  276     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-07-22     Completed Date:  1999-07-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H1951-60     Citation Subset:  IM    
Affiliation:
Copenhagen Muscle Research Centre, Rigshospitalet, and University of Copenhagen, DK-2200 Copenhagen, Denmark. goran@rh.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Adult
Arginine / pharmacology
Blood Pressure / drug effects
Drug Interactions
Enzyme Inhibitors / pharmacology
Exercise / physiology
Femoral Artery / drug effects,  physiology
Heart Rate / drug effects
Humans
Leg / physiology
Male
Muscle, Skeletal / physiology*
Nitric Oxide / physiology*
Nitric Oxide Synthase / antagonists & inhibitors
Nitroprusside / pharmacology
Oxygen Consumption / drug effects
Regional Blood Flow / drug effects
Vasomotor System / physiology*
omega-N-Methylarginine / pharmacology
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 10102-43-9/Nitric Oxide; 15078-28-1/Nitroprusside; 17035-90-4/omega-N-Methylarginine; 51-84-3/Acetylcholine; 74-79-3/Arginine; EC 1.14.13.39/Nitric Oxide Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice.
Next Document:  Heat shock protein expression protects against cerebral ischemia and monoamine overload in rat heats...